Profilo
Christopher Wick worked as a Regional Director-Sales at Alexion Pharmaceuticals, Inc. from 2018 to 2022.
He also worked as an Executive Director & Head-Sales US Region at RELIEF THERAPEUTICS Holding SA. Mr. Wick completed his undergraduate degree from New Mexico State University.
Precedenti posizioni note di Christopher Wick
| Società | Posizione | Fine |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2022 |
| RELIEF THERAPEUTICS HOLDING SA | Sales & Marketing | - |
Formazione di Christopher Wick
| New Mexico State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Aziende private | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher Wick
